IP2Biz® & Investors: Why IP2Biz?
As an investor, you must continue to find a better way to differentiate your funds and your investment model...
Innovation Capital is becoming recognized as one important new way to balance risks in traditional early stage venture investing.
Innovation Capital complements Venture Capital by focusing on earlier stage technologies which have the opportunity to be placed with existing companies. This eliminates operational risk and long periods of illiquidity associated with formation of an operating company.
Exceptional opportunities can often be moved up to startup status after limited amounts of capital have confirmed the efficacy and value of the technology, but before large commitments ar made to the management team and product development initiatives.
IP2Biz answers your needs by...
- Providing a unique, low-risk approach to jump starting new technologies
- Monitoring new technologies, reducing your risk of technology selection
- Verifying -- with objectivity -- technologies ready for release into the commerical arena
- Delivering proof of commercialization through fast and cost-effective testing and validation
- Determining existing patented technology value when teamed with research from other top institutions
- Identifying and evaluating university spinouts that have the right technology and license arrangements to warrant consideration for further investment
- Developing solid relationships with major corporations who can acquire early stage companies
- Facilitating proprietary deal flow, better capital deployment, and greater return on investment.